Tested Applications
| Positive IHC detected in | human breast cancer tissue, human colon cancer tissue, human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10877-1-AP targets PRELID1 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag1037 Product name: Recombinant human PRELID1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-219 aa of BC008307 Sequence: MVKYFLGQSVLRSSWDQVFAAFWQRYPNPYSKHVLTEDIVHREVTPDQKLLSRRLLTKTNRMPRWAERLFPANVAHSVYVLEDSIVDPQNQTMTTFTWNINHARLMVVEERCVYCVNSDNSGWTEIRREAWVSSSLFGVSRAVQEFGLARFKSNVTKTMKGFEYILAKLQGEAPSKTLVETAKEAKEKAKETALAATEKAKDLASKAATKKQQQQQQFV Predict reactive species |
| Full Name | PRELI domain containing 1 |
| Calculated Molecular Weight | 25 kDa |
| GenBank Accession Number | BC008307 |
| Gene Symbol | PRELID1 |
| Gene ID (NCBI) | 27166 |
| RRID | AB_2168787 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9Y255 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for PRELID1 antibody 10877-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The PRELID1 Polyclonal antibody (catalog #10877-1-AP) has 2 total citations. They appear in Frontiers in Immunology (2026), studying gout via multi-omics mapping, and OncoTargets and Therapy (2020), developing an immune gene prognostic signature for hepatocellular carcinoma. Both used the antibody for Western blot in human samples, spanning immunology and oncology research fields.
| Species | Application | Title |
|---|---|---|
Front Immunol Integrated multi-omics mapping of the causal landscape of gout across the circulating-tissue axis. | ||
Onco Targets Ther Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma. |









